Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2009; Volume 197, Supplement 674
Belgian Society for Fundamental and Clinical Physiology and Pharmacology, Autumn Meeting 2009
10/24/2009-10/24/2009
Free University of Brussels, Brussels, Belgium


A NOVEL BINDING SITE IN VOLTAGE GATED POTASSIUM CHANNELS REVEALED BY THE MARINE TOXIN GAMBIEROL
Abstract number: P-11

Kopljar1 I., Labro1 A.J., Cuypers1 E., Rainier1 J., Tytgat1 J., Snyders1 D.

1University of Antwerp, Antwerp-Belgum

Gambierol is a marine polycyclic ether toxin belonging to the group of ciguatera toxins. It does not activate voltage gated sodium channels (VGSC), but inhibits Kv1 potassium channels by an unknown mechanism. While testing whether Kv2, Kv3 and Kv4 channels also serve as targets, we found that Kv3.1 was inhibited with an IC50 of 1.2 ± 0.2 nM while Kv2 and Kv4 channels were insensitive to 1 mM gambierol. Onset of block was similar from either side of the membrane and gambierol did not compete with internal cavity blockers. The inhibition did not require channel opening and could not be reversed by strong depolarization. Using chimeric Kv3.1-Kv2.1 constructs, the toxin sensitivity was traced to S6, in which T427 was identified as a key determinant. In Kv3.1 homology models, T427 and other molecular determinants (L348, F351) reside in a space between S5 and S6 outside the permeation pathway. In conclusion, we propose that gambierol acts as a gating modifier binding to the lipid exposed surface of the pore domain thereby stabilizing the closed state. This site may be the topological equivalent of the neurotoxin site 5 of VGSCs. Further elucidation of this novel binding site may explain why most ciguatoxins activate VGSCs, while others inhibit Kv channels. This novel Kv neurotoxin site may have wide implications not only for our understanding of channel function at the molecular level, but also for future development of drugs to alleviate ciguatera poisoning or to modulate electrical excitability in general.

To cite this abstract, please use the following information:
Acta Physiologica 2009; Volume 197, Supplement 674 :P-11

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE